PGDx Licenses Cell-free Tumor DNA Analysis Technology from Johns Hopkins | GenomeWeb

NEW YORK (GenomeWeb News) – Personal Genome Diagnostics today announced it has licensed the exclusive rights from Johns Hopkins University to a technology for analyzing cell-free tumor DNA circulating in blood.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.